drugset / Trial / NCT01816282

The Use of Fibrin Sealant to Reduce Bleeding After Total Knee Replacement

NCT01816282

Completed 62 enrolled University of Milan
RandomizedParallel-groupSingle-blindTreatment

Summary

A randomized controlled study is performed to address the question of whether the topical application of a novel fibrin sealant, Evicel (Johnson \& Johnson Wound Management, Ethicon, Somerville, NJ) in patient undergoing total knee replacement (TKR) reduce the perioperative blood loss and the need for allogenic blood transfusion compared to a control group. We hypothesize that fibrin sealant decrease the drop in post-operative hemoglobin level after total knee replacement.

Timeline

Start
2011-03
Primary completion
2012-04
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic 5 ml Topical

Indications